The first biological heart valve implanted into a beating heart

December 20, 2013
The first biological heart valve implanted into a beating heart

A few days ago, the cardiac surgeons at the MedUni Vienna and Vienna General Hospital achieved an absolute first: the first biological heart valve implanted into a beating heart was given to a male patient who had a leaky aortic valve. The patient, whose medical care was being provided in Vienna, had aortic regurgitation and was unsuitable for open-heart surgery due to his other co-morbidities.

Trans-catheter aortic valve implantation systems (TAVI) are essentially suitable for older patients with more severe symptomatic narrowing of their aortic valves who require an , but for whom open-heart surgery is associated with increased risk.

Anchoring based on the "paperclip principle"

The new TAVI system is the only one to have CE approval in accordance with the EU Directive on the treatment of patients with aortic regurgitation. Cardiac surgeon Wilfried Wisser from the University Department of Surgery at the MedUni Vienna / Vienna General Hospital explains: "The prosthesis is secured to the native valve leaflets using a clipping mechanism. This mechanism, similar in nature to the 'paperclip principle', allows prostheses to be implanted in too without any calcification."

"Another reason to use the TAVI system is that it allows the prosthesis to be placed in an anatomically correct position. The 'three-sensor element', as it is known, ensures that it is deployed at the correct implantation height and that the prosthesis's connections are optimally aligned with the native valve. And with the new 'Cathlete plus' introducer system, this prosthesis can also be implanted and deployed easily and in a controlled and precise manner," adds Günther Laufer, Head of the Clinical Department of Cardiac Surgery at Vienna General Hospital / MedUni Vienna.

The bioprosthesis is exceptionally durable and, according to the experts, safeguards the long-term function of the aortic valve. The implantation procedure takes place on the beating heart. The flow of blood is maintained, thereby eliminating the risk of cardiac arrest. No cardiac stimulation is required during the implantation procedure.

Explore further: TAVI is safe alternative to redo cardiac surgery

Related Stories

TAVI is safe alternative to redo cardiac surgery

September 2, 2013
TAVI is a safe alternative to redo cardiac surgery for failing bioprosthetic valves, according to research presented at the ESC Congress today by Dr. Spyridon Katsanos from the Netherlands. The findings suggest that transcatheter ...

Heart surgery mortality rates significantly reduced

November 25, 2013
Fifty years have passed since the first heart operation was carried out with a heart-lung machine at the MedUni Vienna in the Vienna General Hospital. Since then cardiac surgery has developed at an astonishing rate – to ...

Gentler heart surgery remains without signs of dementia

December 5, 2013
Aortic valve stenosis is the most frequent heart valve defect of older people in Europe – the cause is usually increasing calcification of this important valve. In patients at high and excessive risk, conventional cardiac ...

Researchers study new heart valve that doesn't require open-heart surgery

October 9, 2013
Northwestern's Bluhm Cardiovascular Institute has enrolled its first participant in SALUS, a clinical trial studying the effectiveness of a prosthetic aortic heart valve that can be placed without open-heart surgery. The ...

TAVI feasible in bicuspid aortic valve

September 2, 2013
Transcatheter aortic valve implantation (TAVI) is feasible in patients with bicuspid aortic valve, according to research presented at ESC Congress 2013 today by Dr. Timm Bauer from Germany. The findings open up a new treatment ...

MDCT helps better determine valve implant size for transcatheter aortic valve in patients with aortic stenosis

April 13, 2013
MDCT is a better way to measure annular size in patients with aortic stenosis who are candidates for transcatheter aortic valve implantation (TAVI) than two dimensional echocardiography, a new study indicates.

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.